What's new

Orphan designation: Resminostat Treatment of hepatocellular carcinoma, 27/09/2011 Withdrawn

Orphan designation: Resminostat Treatment of hepatocellular carcinoma, 27/09/2011 Withdrawn

Jun 5, 2025 - 15:00
 0
Orphan designation: Resminostat Treatment of hepatocellular carcinoma, 27/09/2011 Withdrawn
Orphan designation: Resminostat Treatment of hepatocellular carcinoma, 27/09/2011 Withdrawn
Read More

Tags:

Previous Article

Orphan designation: Recombinant adeno-associated viral vector serotype 5 encodin...

Next Article

Orphan designation: human decorin fused to the truncated homing peptide CRK Trea...

Related Posts

Human medicines European public assessment report (EPAR): Adempas, riociguat, Date of authorisation: 27/03/2014, Revision: 15, Status: Authorised

Human medicines European public assessment report (EPAR...

May 19, 2025  0

Human medicines European public assessment report (EPAR): Ixchiq, Chikungunya vaccine (live), Date of authorisation: 28/06/2024, Revision: 1, Status: Authorised

Human medicines European public assessment report (EPAR...

May 19, 2025  0

Opinion/decision on a Paediatric investigation plan (PIP): Koselugo, Selumetinib, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Congenital, familial and genetic disorders, PIP number: P/0134/2024

Opinion/decision on a Paediatric investigation plan (PI...

Jun 10, 2025  0